Cargando…
Nano-Curcumin Inhibits Proliferation of Esophageal Adenocarcinoma Cells and Enhances the T Cell Mediated Immune Response
In Western countries the incidence of the esophageal adenocarcinoma (EAC) has risen at a more rapid rate than that of any other malignancy. Despite intensive therapies this cancer is associated with extreme high morbidity and mortality. For this reason, novel effective therapeutic strategies are urg...
Autores principales: | Milano, Francesca, Mari, Luigi, van de Luijtgaarden, Wendy, Parikh, Kaushal, Calpe, Silvia, Krishnadath, Kausilia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665944/ https://www.ncbi.nlm.nih.gov/pubmed/23755374 http://dx.doi.org/10.3389/fonc.2013.00137 |
Ejemplares similares
-
Trastuzumab Mediated T-Cell Response against HER-2/Neu Overexpressing Esophageal Adenocarcinoma Depends on Intact Antigen Processing Machinery
por: Milano, Francesca, et al.
Publicado: (2010) -
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
por: Li, Shulin, et al.
Publicado: (2023) -
Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar Lesions
por: Correia, Ana C. P., et al.
Publicado: (2021) -
Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens
por: Hoefnagel, Sanne J. M., et al.
Publicado: (2021) -
Inhibition of the BMP pathway prevents development of Barrett’s-associated adenocarcinoma in a surgical rat model
por: Westra, Wytske M, et al.
Publicado: (2021)